157 related articles for article (PubMed ID: 22025650)
1. The efficacy and cost-effectiveness of statins in low-risk patients.
Gupta AK
CMAJ; 2011 Nov; 183(16):1821-3. PubMed ID: 22025650
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of statins in older adults: further evidence that less is more.
Rich MW
Ann Intern Med; 2015 Apr; 162(8):590-1. PubMed ID: 25894030
[No Abstract] [Full Text] [Related]
3. Statins for primary prevention in older adults.
Ann Intern Med; 2015 Apr; 162(8):I-28. PubMed ID: 25894041
[No Abstract] [Full Text] [Related]
4. Statins for Primary Prevention in Adults Aged 75 Years or Older.
Odden MC; Goldman L; Bibbins-Domingo K
Ann Intern Med; 2015 Sep; 163(6):482. PubMed ID: 26370015
[No Abstract] [Full Text] [Related]
5. Statins for Primary Prevention in Adults Aged 75 Years or Older.
Reidenberg MM
Ann Intern Med; 2015 Sep; 163(6):481. PubMed ID: 26370014
[No Abstract] [Full Text] [Related]
6. Statins for Primary Prevention in Adults Aged 75 Years or Older.
Robinson JG
Ann Intern Med; 2015 Sep; 163(6):481. PubMed ID: 26370013
[No Abstract] [Full Text] [Related]
7. "Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.
Messori A; Santarlasci B; Trippoli S; Vaiani M
BMJ; 2003 Oct; 327(7418):808-9; discussion 809; author reply 809-10. PubMed ID: 14525889
[No Abstract] [Full Text] [Related]
8. Prescribing statins in general practice: who decides?
Steel N; Fleetcroft B; Hassan Y
Br J Gen Pract; 2017 Jun; 67(659):246-247. PubMed ID: 28546390
[No Abstract] [Full Text] [Related]
9. [Statins in primary prevention - a must for the general practitioner?].
Zoller M
Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299
[No Abstract] [Full Text] [Related]
10. Statins for primary prevention in practice: clinical use in Wales and the NICE guideline effect.
Protty MB; Lacey A; Hayes J; Freeman P
Br J Clin Pharmacol; 2016 Sep; 82(3):892-4. PubMed ID: 27260769
[No Abstract] [Full Text] [Related]
11. [Atorvastatin in primary prevention].
Kültürsay H
Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():17-22. PubMed ID: 19404046
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS.
Lafuma A; Colin X; Solesse A
Arch Cardiovasc Dis; 2008 May; 101(5):327-32. PubMed ID: 18656091
[TBL] [Abstract][Full Text] [Related]
13. Statin cost effectiveness in primary prevention: a systematic review of the recent cost-effectiveness literature in the United States.
Mitchell AP; Simpson RJ
BMC Res Notes; 2012 Jul; 5():373. PubMed ID: 22828389
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
de Vries FM; Denig P; Visser ST; Hak E; Postma MJ
Value Health; 2014 Mar; 17(2):223-30. PubMed ID: 24636380
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.
Neyt M; De Laet C; Van Brabandt H; Franco O; Ramaekers D
Acta Cardiol; 2009 Feb; 64(1):1-10. PubMed ID: 19317290
[TBL] [Abstract][Full Text] [Related]
16. Statins for Primary Prevention of Cardiovascular Disease.
Lippi G; Plebani M
Trends Pharmacol Sci; 2017 Feb; 38(2):111-112. PubMed ID: 28017363
[TBL] [Abstract][Full Text] [Related]
17. Statins in primary prevention: is the enthusiasm justified?
Chopra AK; Yadav R
Indian Heart J; 2020; 72(4):221-224. PubMed ID: 32861373
[No Abstract] [Full Text] [Related]
18. The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study.
Marshall T
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):523-8. PubMed ID: 16874140
[TBL] [Abstract][Full Text] [Related]
19. Statins for primary prevention.
Tejani AM; Musini V; Bassett K; Dormuth C; Perry T; Wright JM
CMAJ; 2012 Apr; 184(7):791; author reply 791-2. PubMed ID: 22508992
[No Abstract] [Full Text] [Related]
20. New guidelines on hypertension.
Mackenzie DG; Forbes JF; Rutledge P
Lancet; 2006 Aug; 368(9536):641. PubMed ID: 16920456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
